Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HW.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HW.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HW.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HW.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GE.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GE.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GE.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCHORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCHNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JF.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JD.1.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCKORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.5.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GW.5.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.5.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used